{"id":"NCT01737762","sponsor":"Healthpoint","briefTitle":"Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2","officialTitle":"A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11","primaryCompletion":"2015-11","completion":"2015-11","firstPosted":"2012-11-30","resultsPosted":"2017-07-26","lastUpdate":"2017-07-26"},"enrollment":155,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Venous Leg Ulcers"],"interventions":[{"type":"BIOLOGICAL","name":"HP802-247","otherNames":[]},{"type":"BIOLOGICAL","name":"Vehicle","otherNames":[]}],"arms":[{"label":"HP802-247","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being done to find out if an investigational product called HP802-247 can help people with venous leg ulcers. Investigational means that HP802-247 has not been approved by the U.S. Food and Drug Administration (FDA).\n\nAt least 250 subjects will participate. The study is going to be conducted in approximately 50 sites in the United States and Canada.","primaryOutcome":{"measure":"Wound Closure","timeFrame":"16 Weeks","effectByArm":[{"arm":"HP802-247","deltaMin":17,"sd":null},{"arm":"Vehicle","deltaMin":23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":9},"locations":{"siteCount":43,"countries":["United States","Canada","Puerto Rico"]},"refs":{"pmids":["29037354"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":77},"commonTop":["Skin ulcer","Cellulitis","Wound complication","Infected skin ulcer","Wound infecton"]}}